From Seven Bridges Gets $45M, Begins Test Run for Cancer Genomics Tool:

Deniz Kural and James Sietstra
Deniz Kural and James Sietstra

Seven Bridges Genomics CEO Deniz Kural (left) and president James Sietstra (right).